Influenza News and Research

Latest Influenza News and Research

Rare variants of type I IFN immunity genes could underlie life-threatening COVID-19

Researchers assessed whether loss-of-function variants of type I interferon immunity genes are associated with life-threatening COVID-19.

27 Oct 2022

Vaccination- and/or natural infection-induced immune responses against SARS-CoV-2 Omicron subvariants

Researchers comparatively evaluated the neutralization antibody titers for SARS-CoV-2 Omicron VOC subvariants BA.1, BA.2, BA.4/5 among individuals with ancestral B.1 strain infections, vaccinated individuals, or with hybrid immunity from breakthrough infections and vaccinations with Delta or Gamma VOCs.

27 Oct 2022

Study reveals conserved and divergent host responses to infections with SARS-CoV-2 variants of concern

Researchers analyzed the phenotypes of the SARS-CoV-2 variants of concern (VOCs), the molecular responses to infections from these VOCs, and the evolving virus-host interactions using a comparative genomic and proteomic approach.

26 Oct 2022

SARS-CoV-2 BQ.1 variant cases may increase in Europe

A recent epidemiological update by the European Center for Disease Prevention and Control indicated that a new SARS-CoV-2 Omicron sublineage was likely to increase COVID-19 case numbers.

26 Oct 2022

A review of emerging pediatric respiratory viruses

Respiratory viruses continue to be a leading cause of childhood morbidity and mortality.

26 Oct 2022

Did COVID-19 mitigation measures in the United Kingdom impact the transmission of other infectious diseases?

Researchers explored the impact of the coronavirus disease 2019 (COVID-19) pandemic-associated non-pharmaceutical prevention measures on the transmission of 22 infectious diseases in England.

25 Oct 2022

Avian influenza virus introduced from Europe to North America through Iceland

A new study indicated that Iceland was the stepping stone for the translocation of the highly pathogenic avian influenza virus (HPAIV) between North America and Europe.

25 Oct 2022

Researchers design a COVID-19 vaccine construct using hybrid SARS-CoV-2 spike protein and nucleocapsid protein peptides

Researchers designed a COVID-19 vaccine construct using hybrid SARS-CoV-2 S protein (containing SARS-CoV-2 Delta and Omicron variant mutations) and N protein peptides that confer T lymphocyte-mediated immune protection.

25 Oct 2022

What is the efficacy of mulberry component Kuwanon C against COVID-19?

A recent study determined the underlying antiviral mechanism of KC associated with the inhibition of SARS-CoV-2.

24 Oct 2022

A study of Moderna's COVID vaccine in children aged 6 months to 5 years

In a recent study published in the New England Journal of Medicine, researchers presented the findings of the ongoing KidCOVE trial in the United States (US).

23 Oct 2022

FebriDX point-of-care immunoassay can rapidly determine if an infection is bacterial or viral

Researchers explore whether FebriDx could differentiate between bacteria- and virus-induced immune responses during acute respiratory infection.

23 Oct 2022

Regenstrief Institute and Indiana Department of Health partner on an influenza surveillance data pilot study

Regenstrief Institute and the Indiana Department of Health are collaborating on an influenza surveillance data pilot study to provide in-depth data and analysis of the spread of Influenza in Indiana, similar to how Regenstrief has provided data on COVID-19.

20 Oct 2022

Racial, ethnic disparities found in flu vaccination coverage and hospitalization rates

Black, Hispanic, and American Indian/Alaska Native (AI/AN) adults in the United States are more likely to be hospitalized with flu, as well as less likely to be vaccinated against flu, according to a new CDC Vital Signs report.

20 Oct 2022

Differential effects of SARS-CoV-2 variants on children and adolescents

A recent Emerging Infectious Diseases journal study evaluated whether specific SARS-CoV-2 variants were linked with different clinical manifestations in children and adolescents.

19 Oct 2022

Rapid and robust pipeline for developing mRNA vaccines for future SARS-CoV-2 variants

A recent study under review at the journal Scientific Reports and currently available on the Research Square* preprint server reported the development of a robust pipeline for fabricating an mRNA vaccine portfolio to combat current and future coronavirus outbreaks, other infectious diseases, and cancer.

19 Oct 2022

Influenza News and Research

Latest Influenza News and Research

Rare variants of type I IFN immunity genes could underlie life-threatening COVID-19

Vaccination- and/or natural infection-induced immune responses against SARS-CoV-2 Omicron subvariants

Study reveals conserved and divergent host responses to infections with SARS-CoV-2 variants of concern

SARS-CoV-2 BQ.1 variant cases may increase in Europe

A review of emerging pediatric respiratory viruses

Did COVID-19 mitigation measures in the United Kingdom impact the transmission of other infectious diseases?

Avian influenza virus introduced from Europe to North America through Iceland

Researchers design a COVID-19 vaccine construct using hybrid SARS-CoV-2 spike protein and nucleocapsid protein peptides

What is the efficacy of mulberry component Kuwanon C against COVID-19?

A study of Moderna's COVID vaccine in children aged 6 months to 5 years

FebriDX point-of-care immunoassay can rapidly determine if an infection is bacterial or viral

Regenstrief Institute and Indiana Department of Health partner on an influenza surveillance data pilot study

Racial, ethnic disparities found in flu vaccination coverage and hospitalization rates

Differential effects of SARS-CoV-2 variants on children and adolescents

Rapid and robust pipeline for developing mRNA vaccines for future SARS-CoV-2 variants

Scientists develop a pseudovirus system to deep mutational scan the full SARS-CoV-2 spike

Study reviews human judgment ensemble during Omicron BA.1 wave in the USA

Recent innovations in infectious disease diagnostics

Researchers explore the development of mRNA vaccines against respiratory syncytial virus

Scoping study of COVID-19 epidemiologic data and epidemiologic research relevant to pandemic management in the US

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Influenza News and Research

Latest Influenza News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in